GlaxoSmithKline plc announced that the FDA has on 20 August 2014 approved Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily...
GlaxoSmithKline has received approval from the FDA for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS)...